In Reply: Antiobesity drug therapy

[摘要] In Reply: I thank Dr. Modarressi for these comments and agree that the impact of many glucagon-like peptide 1 (GLP-1) receptor agonists on the lowering of blood pressure is modest but significant when com- pared with other glucose-lowering agents and thus have exerted cardioprotective benefits.

[学科分类] 卫生学